Cargando…

Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions

Drug-eluting stents (DES) have been widely applied for saving the life of patients with coronary artery diseases (CADs). However, conventional polymers such as polylactic acid (PLA) and poly (lactic-co-glycolic acid) (PLGA), which are widely applied for drug-eluting stents studies, have serious bulk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Ruixia, Wu, Leigang, Wang, Jin, Yang, Zhilu, Tu, Qiufen, Zhang, Xingcai, Huang, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406385/ https://www.ncbi.nlm.nih.gov/pubmed/30781704 http://dx.doi.org/10.3390/biom9020069

Ejemplares similares

A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent
por: Chen, Yin, et al.
Publicado: (2021)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
por: Ma, Qing, et al.
Publicado: (2021)

Mimicking the Nitric Oxide‐Releasing and Glycocalyx Functions of Endothelium on Vascular Stent Surfaces
por: Lyu, Nan, et al.
Publicado: (2020)

Mimicking the Nitric Oxide‐Releasing and Glycocalyx Functions of Endothelium on Vascular Stent Surfaces
por: Lyu, Nan, et al.
Publicado: (2021)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Polyurethane membrane with porous surface for controlled drug release in drug eluting stent
por: Seo, Eun Ha, et al.
Publicado: (2014)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

The relationship between re-endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting stent
por: Murase, Suguru, et al.
Publicado: (2014)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents
por: Choi, Woong Gil, et al.
Publicado: (2015)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Drug-eluting metallic stents in urology
por: Kallidonis, Panagiotis S., et al.
Publicado: (2014)

Optimization of Drug Delivery by Drug-Eluting Stents
por: Bozsak, Franz, et al.
Publicado: (2015)

Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents: An updated meta-analysis
por: Chen, Yun-lin, et al.
Publicado: (2019)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Advances in drug eluting stents – focus on the Endeavor(®) zotarolimus stent
por: Bridges, Jonathan, et al.
Publicado: (2008)

Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification
por: Douglas, Gillian, et al.
Publicado: (2013)

Drug Release Analysis and Optimization for Drug-Eluting Stents
por: Li, Hongxia, et al.
Publicado: (2013)

Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents
por: Akinapelli, Abhilash, et al.
Publicado: (2017)

Drug-Eluting Stent: A Review and Update
por: Htay, Thein, et al.
Publicado: (2005)

Pathological Perspective of Drug-Eluting Stent Thrombosis
por: Inoue, Katsumi
Publicado: (2012)

Functional Nanoarchitectures For Enhanced Drug Eluting Stents
por: Saleh, Yomna E., et al.
Publicado: (2017)

Drug-eluting stents: insights into safety and indications
por: Hassan, Walid
Publicado: (2008)

Are Drug Eluting Stents Worth Triple Therapy?
por: Heidenreich, Paul
Publicado: (2017)

Drug-Eluting Stents: Technical and Clinical Progress
por: Koźlik, Maciej, et al.
Publicado: (2023)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
por: Whitbeck, Matthew G., et al.
Publicado: (2013)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

CURRENT DEVELOPMENTS IN DRUG ELUTING DEVICES: Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
por: Spadaccio, Cristiano, et al.
Publicado: (2017)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Pathogenesis of late in-stent thrombosis after treatment with drug-eluting stents
por: Hao, Hiroyuki
Publicado: (2012)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
por: Tang, Xiao-Fang, et al.
Publicado: (2018)

Meta-analysis of outcomes from drug-eluting stent implantation in infrapopliteal arteries
por: Li, Ming-Xuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kjsoiu4olr0jip8olq40qmqha7